MAIA Biotechnology, Inc. (MAIA)
1.29
+0.02
(+1.57%)
USD |
NYAM |
Jun 09, 16:00
1.32
+0.03
(+2.33%)
After-Hours: 20:00
MAIA Biotechnology SG&A Expense (Quarterly) : 3.425M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| TG Therapeutics, Inc. | 88.22M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Alnylam Pharmaceuticals, Inc. | 322.55M |
| Savara, Inc. | 15.57M |
| Vericel Corp. | 49.23M |